LARIMAR THERAPEUTICS
7.0200
08-十月-24 11:36:14
15 分钟延时
股票
+0.5400
+8.33%
今日范围
6.4500 - 7.1300
ISIN
N/A
来源
NASDAQ
-
Larimar Therapeutics to Participate in the Guggenheim Genomic Medicines and Rare Disease Days
28 3月 2023 15:05:00 条件 Nasdaq GlobeNewswire
-
Larimar Therapeutics Reports Fourth Quarter and Full Year 2022 Operating and Financial Results
14 3月 2023 06:00:01 条件 Nasdaq GlobeNewswire
-
Larimar Therapeutics Appoints Dr. Gopi Shankar as Chief Development Officer
07 2月 2023 15:05:00 条件 Nasdaq GlobeNewswire
-
Larimar Therapeutics to Present at the 34th Annual Piper Sandler Healthcare Conference
21 11月 2022 15:05:00 条件 Nasdaq GlobeNewswire
-
Larimar Therapeutics Reports Third Quarter 2022 Operating and Financial Results
10 11月 2022 06:00:04 条件 Nasdaq GlobeNewswire
-
Larimar Therapeutics to Participate in the Guggenheim 4th Annual Immunology & Neurology Day
07 11月 2022 15:05:01 条件 Nasdaq GlobeNewswire
-
20 10月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
19 10月 2022 15:05:00 条件 Nasdaq GlobeNewswire
-
16 9月 2022 12:00:00 条件 Nasdaq GlobeNewswire
-
Larimar Therapeutics Announces $70 Million Underwritten Offering
14 9月 2022 06:04:00 条件 Nasdaq GlobeNewswire
-
14 9月 2022 06:01:00 条件 Nasdaq GlobeNewswire
-
28 7月 2022 15:05:00 条件 Nasdaq GlobeNewswire
-
28 6月 2022 07:00:02 条件 Nasdaq GlobeNewswire
-
Larimar Therapeutics Announces Upcoming Scientific Conference Presentations
02 6月 2022 07:00:02 条件 Nasdaq GlobeNewswire
-
19 5月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
Larimar Therapeutics Reports First Quarter 2022 Operating and Financial Results
12 5月 2022 06:00:02 条件 Nasdaq GlobeNewswire
-
Larimar Therapeutics Reports Fourth Quarter and Full Year 2021 Operating and Financial Results
25 3月 2022 06:00:00 条件 Nasdaq GlobeNewswire
-
Larimar Therapeutics Provides Update on CTI-1601 Clinical Program
14 2月 2022 15:01:00 条件 Nasdaq GlobeNewswire